Health agencies will share cancer drug data

Health agencies will share cancer drug data

The Food and Drug Administration and the National Cancer Institute are teaming to up to build a grid-computing system that will let drug researchers share developmental data about cancer drugs.

The initiative will let researchers electronically submit applications to investigate new drugs, FDA commissioner Mark McClellan said. It also will give cancer researchers online access to FDA’s drug review databases, letting them access and evaluate clinical trial data, he said.

The effort is part of the cancer institute’s broader online initiative, the Cancer Biomedical Informatics Grid Project.

McClellan described the data-sharing project yesterday at a meeting of the President’s Information Technology Advisory Committee in Arlington, Va.

The project sprang from an interagency task force formed in May to study ways to expedite the review process for new cancer drugs.

For more information about the grid project, click on caBIG site.

About the Author

Connect with the GCN staff on Twitter @GCNtech.

Featured

  • Defense
    Ryan D. McCarthy being sworn in as Army Secretary Oct. 10, 2019. (Photo credit: Sgt. Dana Clarke/U.S. Army)

    Army wants to spend nearly $1B on cloud, data by 2025

    Army Secretary Ryan McCarthy said lack of funding or a potential delay in the JEDI cloud bid "strikes to the heart of our concern."

  • Congress
    Rep. Jim Langevin (D-R.I.) at the Hack the Capitol conference Sept. 20, 2018

    Jim Langevin's view from the Hill

    As chairman of of the Intelligence and Emerging Threats and Capabilities subcommittee of the House Armed Services Committe and a member of the House Homeland Security Committee, Rhode Island Democrat Jim Langevin is one of the most influential voices on cybersecurity in Congress.

Stay Connected

FCW INSIDER

Sign up for our newsletter.

I agree to this site's Privacy Policy.